ABI3 Is a Novel Early Biomarker of Alzheimer's Disease.

MLA

Cao, Min, et al. “ABI3 Is a Novel Early Biomarker of Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 87, no. 1, May 2022, pp. 335–44. EBSCOhost, https://doi.org/10.3233/JAD-215635.

APA

Cao, M., Liu, J., Zhang, X., Yang, T., Wang, Y., Hou, Y., Song, Q., Cui, Y., Wang, Y., & Wang, P. (2022). ABI3 Is a Novel Early Biomarker of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 87(1), 335–344. https://doi.org/10.3233/JAD-215635

Chicago

Cao, Min, Jing Liu, Xiaomin Zhang, Tingting Yang, Yaqi Wang, Yuli Hou, Qiao Song, Yuting Cui, Yifei Wang, and Peichang Wang. 2022. “ABI3 Is a Novel Early Biomarker of Alzheimer’s Disease.” Journal of Alzheimer’s Disease 87 (1): 335–44. doi:10.3233/JAD-215635.